By |

Profile

Cepheid was incorporated in the State of California on March 4, 1996. The Company is a molecular diagnostics company that develops, manufactures and markets integrated systems for testing in the clinical market, as well as for application in its non-clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's product portfolio consists of tests, reagents and systems for the clinical and non-clinical markets. The Company's two systems are the GeneXpert and SmartCycler. The GeneXpert system, offers services in the clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors' offices.

Contact Information

Website: www.cepheid.com
Email: investor.relations@cepheid.com
Main Phone: +1 408 541-4191
Address: 904 Caribbean Drive
State: CA
City / Town: Sunnyvale
Country: USA
Postal Code: 94089-1189

Issuer Information

Exchange: NGS
CEO: John L. Bishop
Employees: 1700
NAICS: Analytical Laboratory Instrument Manufacturing(334516)


Gathering Data... Please wait

Profile

Cepheid was incorporated in the State of California on March 4, 1996. The Company is a molecular diagnostics company that develops, manufactures and markets integrated systems for testing in the clinical market, as well as for application in its non-clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's product portfolio consists of tests, reagents and systems for the clinical and non-clinical markets. The Company's two systems are the GeneXpert and SmartCycler. The GeneXpert system, offers services in the clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors' offices.

Contact Information

Website: www.cepheid.com
Email: investor.relations@cepheid.com
Main Phone: +1 408 541-4191
Address: 904 Caribbean Drive
State: CA
City / Town: Sunnyvale
Country: USA
Postal Code: 94089-1189

Issuer Information

Exchange: NGS
CEO: John L. Bishop
Employees: 1700
NAICS: Analytical Laboratory Instrument Manufacturing(334516)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 53.91 52 Wk Low 25.09
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 73,007,168.00 EPS (TTM) -0.51 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Cristina H. Kepner 1,000
Cristina H. Kepner 1,000
Joseph H. Smith 1,000
Cristina H. Kepner 1,000
Dean O. Morton 1,000
Dean O. Morton 1,000
Last 10 Sell Shares
Scott A. Campbell 1,000
Scott A. Campbell 1,000
Scott A. Campbell 1,000
Scott A. Campbell 1,000
Scott A. Campbell 1,000
Peter Farrell 1,000
Peter Farrell 1,000
John L. Bishop 1,000
Peter Farrell 1,000
Robert J. Easton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 53 53 53 53
Low Target Price Estimate 34 34 34 34
Mean Target Price Estimate 45 45 45 45
Standard Deviation 8.72 8.72 8.72 8.72
Date of Most Recent Estimate 11/04/16 11/04/16 11/04/16 11/04/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 2 6
Moderate Buy 0 0 0 1
Hold 11 14 12 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.83 2.87 2.71 2.13